Drug Discovery Outsourcing Market to Reach $7.4 Billion by 2031 at 7.5% CAGR Driven by Rising R&D Efficiency Needs
According to the new report published by Allied Market Research, the global drug discovery outsourcing market is experiencing steady growth as pharmaceutical and biotechnology companies increasingly rely on external partners to accelerate research and development processes. The market was valued at $3.6 billion in 2021 and is projected to reach $7.4 billion by 2031, growing at a CAGR of 7.5% from 2022 to 2031. Drug discovery outsourcing involves delegating various stages of drug development, including target identification, lead optimization, and preclinical testing, to specialized contract research organizations. The increasing complexity of drug development and the need to reduce time-to-market are major factors driving the demand for outsourcing services. Pharmaceutical companies are focusing on improving efficiency while minimizing operational costs, leading to a growing reliance on external expertise. This trend is expected to significantly contribute to the expansion of the ...